StockWatch
·
KUANTUM PAPERS LTD. · QQ2 FY-2027 · THE CALL

Profit collapse clouds PM3 win; margin recovery unproven

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsKUANTUMKUANTUM PAPERS LTD.03 Nov 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade C

H1 PAT only ₹9 Cr (1.5% margin) falls sharply short of prior 16-18% EBITDA margin target. Q2 specifically shows -61% YoY profit decline and -64% QoQ decline. Implicit margin guidance downgrade is material miss.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

PM3 capex delivery (59 days, record timing) is a genuine operational win with 15-17% cost reduction and 675 tpd capacity online. However, Q2 profit collapsed 61% YoY to ₹2.2 Cr on thin 0.8% margin, EBITDA margin guidance has been implicitly cut from 16-18% to 14%, and 7-11% price-hike recovery in H2 is still unproven. Risk is high: debt peaks at ₹700 Cr, input costs remain elevated, and market demand shifts to lower-GSM products that constrain premium pricing.

₹279.1 Cr

Revenue · −0.2% YoY

₹2.2 Cr

Reported PAT · −61.2% YoY

Compressing

Margins · vs guidance: Overstated

Did the claims hold up?

Management's claims vs. the numbers

PM3 commissioned 28 Aug in record 59 days vs 65 planned

MET

Confirmed on call; delivered capability at 675 tpd vs prior 600 tpd

Cost reduction 15-17% achieved in raw materials and fuel

MET

Jagdeep Hira stated both agro and wood reduction achieved; specific %age supported

H1 FY27 revenue growth 16% YoY to ₹533 Cr

MET

CFO stated operational income ₹533 Cr in H1; aligns with 16% growth metric

EBITDA margin guidance 16-18% by year-end FY27

MISS

Now guiding ~14% for FY27 (Pushkar Jain: '14% for this year', Pavan confirmed 'Sure, sure')

Price hikes 7-11% expected in H2 FY27

Mixed

Stated in call; only ~4% realized to date, full realization pending market acceptance

Highest monthly copier production 4,482 metric tons in Aug 2026

MET

Call confirms; part of PM3 ramp benefits

Earnings quality

What changed since the last call

Deltas vs. the prior call

EBITDA margin guidance cut

Downgrade

Prior guidance 16-18% by FY27 year-end; now implicitly 14% for full FY27 (from Pushkar Jain Q&A exchange). Material miss vs prior target.

Cost pressure narrative shift

Downgrade

H1 call likely guided cost absorption via operational leverage; H2 now dependent on price hikes. Only 4% realized, 7-11% needed.

Peak debt now visible

Neutral

Prior guidance 'peak debt ₹760-770 Cr'; now at ₹700 Cr and stated as peak. Debt reduction commences FY27 onward per plan.

Specialty paper portfolio expansion timeline

New

Added target: 25-30% specialty mix within 12-15 months (now at 17-18%). Concrete timeline and product mix strategy stated.

The Q&A

Analysts pressed hard on cost details (Saania Jain), margin recovery timing (Utkarsh Nopany, Arjun Tambe), GSM mix constraints (Rishi Mody), and capital allocation (Rishi Mody on buybacks). Management held firm on price hike assumptions (7-11%) and debt reduction plan but was evasive on absolute cost figures and refused to quantify some inputs; credibility somewhat eroded.

The exchanges that mattered

West Asia cost impact — Saania Jain, Care PMS

Answered

~2% impact on cost of sales quarterly; sulfuric acid and other chemicals most affected; impact quarterly basis

PM3 shutdown impact — Madhav Jhawar, SKP Securities

Answered

~6,300 tons production loss; ~₹40 Cr EBITDA impact. Loss primarily from PM3, inventory adjustment minimal

Price hike sustainability — Utkarsh Nopany, Anand Rathi

Partial

Price hikes to be sustained at least 2 quarters in H2. Market and sector tailwinds; not temporary aberration

Capacity and Environmental clearance — Niteen Dharmawat, Aurum Edge

Partial

EC application filed; approvals likely soon. Capacity optimized at ~600 tpd market-driven, not constraint-driven

Price hike numbers H2 — Samarth Singh, TPF Capital

Answered

Expecting 7% to 11% price range in Q3-Q4. ADD already in place for kraft paperboard; writing-printing MIP under investigation, 3-6 month timeline

Cost share of starch and coal — Utkarsh Nopany, Anand Rathi

Partial

Starch ~2-2.5% of paper cost; coal impact significant due to power-sector diversion; inflation expected to continue but moderation targeted by Nov-Dec

Debt and deleverage timeline — Arjun Vinay Tambe, Aurevia Crest

Answered

Peak debt ₹700 Cr; interest/depreciation impact 3-3.5% next 2 years. Better business prospect FY27, 28 will enable deleveraging. Next financial year should reach 18-20% EBITDA

Capital expenditure and depreciation — Madhav Jhawar, SKP Securities

Answered

Capex fully exercised; no further amounts to forecast. Depreciation ~₹80 Cr annually

GSM mix and capacity constraints — Rishi Mody, Mody Advisory

Answered

Capability to produce 675 tpd; market trending lower so we optimize at 600 tpd. Specialty papers (70-90 gsm) and industrial mix is the strategy; product mix being adjusted daily based on market

Margin guidance FY27 and H2 — Pushkar Jain, Mili Capital

Answered

14% margin guidance for FY27. Hopefully 17-18% for second half (implying FY28 H1). Current cost inflation temporary; should normalize by Nov-Dec

Government support ADD and MIP — Samarth Singh, TPF Capital

Answered

MIP for kraft/paperboard segment accepted and notified; writing-printing MIP under investigation with 3-6 month timeline expected. Government bodies supportive; ASP (Antidumping Structural Price) duty in place

Tissue line and market consolidation — Ranveer Kataria, BRK

Answered

No tissue line entry currently. Consolidation happening (ITC-Century, JK acquiring smaller players); we are not consolidating, building our own specialty mix

China paper market outlook and competition — Aaryan, AV Investments

Answered

China is not in bad economy; facing demand issues. Chenming, Nine Dragons closed operations. Indonesia declining. Our outlook: imports stable, exports down, supply-demand balance favourable long-term

Capital allocation and buybacks — Rishi Mody, Mody Advisory

Answered

Clear focus on generating rightful cash flow to repay and service debt. No changes in equity capital structures or buyback plans. Debt repayment is priority

Guidance

Forward guidance and management's confidence

FY27 annual sales value target ₹1,300 Cr+

High

H1 ₹533 Cr (pace ₹1,066 Cr annualized); ₹1,300 Cr requires strong H2. Management reaffirmed commitment but Q2 momentum (-8% QoQ) suggests execution risk

FY27 EBITDA margin ~14% (implied; prior 16-18%)

Medium

Cut from prior 16-18% guidance. H1 EBITDA margin ~14% (₹75Cr / ₹533Cr); Q2 shutdown depressed, but base case still weak. Q3-Q4 depend on price hikes (7-11%)

FY28 EBITDA margin target 18-20%

Low

Long-term ambition; contingent on price hike realization, cost normalization, and specialty portfolio mix (25-30%). No quarterly bridging provided

H2 FY27 margin ~14% (Pushkar Jain Q: 'Our margin target will be like 14% for this year and hopefully 17, 18 for the second half?', Pavan: 'Sure, sure')

Medium

17-18% margin is for FY28 H1 (next financial year), not H2 FY27. Clear downgrade from prior 16-18% FY27 guidance

Capex fully completed; no further major capex forecasted in near term

High

PM3 capex complete as of Aug 2026. Management stated capex is 'completely exercised' and 'no further amounts to forecast'. Environment projects (lime kiln, CNCGI) remaining for implementation

Risks the call surfaced

Ranked by how much they should concern a holder

Margin recovery risk

High

Only 4% price hike realized to date vs 7-11% needed for full offset. West Asia war, coal shortage, starch inflation ongoing. Market competitive dynamics limit pricing power.

Profit erosion / leverage

High

Peak debt at ₹700 Cr; PAT collapsed 61% YoY in Q2. If margins don't recover to 14%+ in H2-FY28, interest coverage erodes and leverage becomes stressed.

Product mix/capacity constraint

Medium

PM3 capex increased capacity to 675 tpd; however, market trending toward lower GSMs (52, 54, 58) vs 64 GSM anchor. Company forced to operate at 600 tpd optimized level, limiting capex ROI.

Geopolitical/macro

Medium

Ocean freight volatility, coal supply diversion to power plants, global supply chain disruptions. Conflicts in West Asia reducing export volumes and increasing cost of chemical imports (sulfuric acid).

Government policy/subsidy

Low

MIP for kraft segment in place; but writing-printing paper MIP still under investigation (3-6 month timeline). ADD (antidumping duties) also key for support.

Execution risk

Medium

PFAS-free GSM paper launched Q3; specialty portfolio target 25-30% in 12-15 months. If customer adoption lags or pricing doesn't support target margins, specialty pivot may disappoint.

Management

Score 6/10. Mixed. Strong on operational metrics (PM3 execution, cost reduction %). Weak on transparency: refused absolute cost figures ('we won't be able to exhibit right now'), vague on price hike timing ('towards the end' initially), evasive on GSM product mix trade-offs. Some candor on challenges (West Asia, seasonal weakness) but defensive posture at times. Good on capex: PM3 delivered in 59 days vs 65-day plan (ahead of schedule). Weak on guidance: FY27 margin guidance implicitly cut from 16-18% to 14%; H1 PAT ₹9 Cr falls far short of prior-year run-rate expectations. Track record: met revenue pace but profit substantially below guidance.

What to watch next
  • 1 · Nov–Dec 2026

    Price realization target 7-11% in H2; market normalization post-Diwali

  • 2 · Q3 FY27 (Oct–Dec 2026)

    PM3 full-quarter operational (no shutdown), benefits realized; specialty paper launch (PFAS-free GSM oil/grease paper launched Q3)

  • 3 · 3-6 months (likely Q4 FY27 or later)

    Government decision on writing-printing paper MIP (already decided for paperboard); impacts segment economics

Risk is high: debt peaks at ₹700 Cr, input costs remain elevated, and market demand shifts to lower-GSM products that constrain premium pricing.

Informational and educational content only. Not investment advice.